A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: Age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes

Liver

Volumn 19, Issue 2, 1999, Pages 88-96

  Kuboki, Makoto ^b   Shinzawa, Haruhide ^a   Shao, Li ^b   Ishibashi, Masamichi ^b   Yoshii, Eiichi ^b   Suzuki, Katunori ^b   Saito, Koji ^b   Saito, Takafumi ^b   Togashi, Hitoshi ^b   Takahashi, Tsuneo ^a   Yasumura, Seiji ^b   Fukao, Akira ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b NONE

Author keywords

Age; Aminotransferase; Anti HCV; Epidemiology; Hepatitis C virus (HCV); HGV RNA; Liver histology; Sex

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; COHORT ANALYSIS; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEPATITIS C VIRUS; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PREVALENCE; REGRESSION ANALYSIS; SCHOOL CHILD; SEROPREVALENCE; VIREMIA; VIRUS INFECTION;

EID: 0032994022     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00016.x     Document Type: Article

References (40)

1. THURSZ M R, THOMAS H C. Host factors in chronic viral hepatitis. Semin Liv Dis 1997; 17: 345-50.
2. ALTER M J. Epidemiology of hepatitis C. Hepatology 1997; 16: 62S-5S.
3. DUBOIS F, DESENCLOS J C, MARRIOTE N, GOUDEAU A. Hepatitis C in a French population-based survey. 1994:seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997; 25: 1490-6.
4. SERFATY L, NOUSBAUM J B, ELGHOUZZI M H, GIRAL P, LEGENDRE C, POUPON R. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Hepatology 1995; 21:725-9.
5. YAMAKAWA Y, SATA M, SUZUKI H, NOGUCHI S, TANIKAWA K. Higher elimination rate of hepatitis C virus among women. J Viral Hepat 1996; 3: 317-21.
6. KUBOKI M, SHINZAWA H, TOGASH H, et al. Retrospective follow-up study of prevailing hepatitis in Nagai City and its vicinity in Japan. Acta Hepatol Jpn 1991; 32: 229-34.
7. OKAMOTO H, OKADA S, SUGIYAMA Y, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 1990; 60: 167-77.
8. GRETCH D R. Diagnostic tests for hepatitis C. Hepatology 1997; 26(3Suppl 1): 43S-7S.
9. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
10. SIMMONDS P, HOLMES E C, CHA T-A, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenelic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-9.
11. KEYS A, FIDANZA F, KARVONEN M J, KIMURA N, TAYLOR H L. Indices of relative weight and obesity. J Chronic Dis 1972; 25: 329-43.
12. DE GROOTE J, DESMET V J, GEDIGK P, et al. A classification of chronic hepatitis. Lancet 1968; ii (568): 626-8.
13. NANU A, SHARMA S P, CHATTERJEE K, JYOTI P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang 1997; 73: 70-3.
14. YAMAGUCHI K, KIYOKAWA H, MACHIDA J, OBAYASHI A, NOJIRI N, et al. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. FEMS Microbiol Rev 1994; 14: 253-8.
15. VRIELINK H, REESINK H W, VAN DEN BURG P J, et al. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion 1997; 37: 845-9.
16. ESTEBAN J I, ESTEBAN R, VILADOMIU L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; II: 294-6.
17. KIYOSAWA K, TANAKA E, SODEYAMA T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The south Kiso Hepatitis Group. Gastroenterology 1994; 106: 1596-602.
18. HAYASHI J, NAKASHIMA K, YOSHIMURA E, HIRATA M, MAEDA Y, KASHIWAGI S. Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan. J Gastroenterol 1994; 29: 147-51.
19. TANAKA H, HIYAMA T, TSUKUMA H, et al. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994; 5: 409-13.
20. ALTER M J, MARGOLIS H S, KRAWCZYNSKI K, et al. The natural history of community acquired hepatitis C in the United states. N Engl J Med 1992; 327: 1899-905.
21. MAUSER-BUNSCHOTEN E P, BRESTERS D, VAN DRIMMELEN A A, et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995; 45: 241-6.
22. DARMADI S, SOETJIPTO, HANDAJARI R, et al. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia. Microbiol Immunol 1996; 40: 401-5.
23. SAWADA M, TAKADA A, TAKASE S, TAKADA N. Effect of alcohol on the replication of hepatitis C virus. Alcohol Alcohol Suppl 1993; 1B: 85-90.
24. DUBOIS DB, GRETCH D, DELA ROSA C, et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load. Am J Kidney Dis 1994; 24: 795-801.
25. SHAKIL A O, CONRY-CANTILENA C, ALTER H J, HAYASHI P, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995; 123: 330-7.
26. CASPARI G, GERLICH W H, BEYER J, SCHMITT H. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors. Arch Virol 1997; 142: 473-89.
27. SMITH B C, CHAPMAN C E, BURT A D, TOMS G L, BASSENDINE M F. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors. QJM 1997; 90: 587-92.
28. GRELLIER L, BROWN D, POWER J, DUSHEIKO G. Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977. J Viral Hepat 1997; 4: 379-81.
29. MATTSSON L, SONNERBORG A, WEILAND O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver 1993; 13: 274-8.
30. SEEFF L B. Natural history of hepatitis C. Hepatology 1997; 26(3Suppl 1): 21S-8S.
31. PUOTI C, MAGRINI A, STATI T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997; 26: 1393-8.
32. GHOLSON C F, MORGAN K, CATINIS G. et al. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol 1997; 92: 1788-92.
33. KNODELL R G, ISHAK K G, BLACK W C, et al. Formation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
34. SHEV S, DHILLON A P, LINDH M, et al. The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver 1997; 17: 215-23.
35. STRASSER S I, WATSON K J, LEE C S, COGHLAN P J, DESMOND P V. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 1995 3; 162: 355-8.
36. VAQUER P, CANET R, LLOMPART A, RIERA J, OBRADOR A, GAYA J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994; 14: 265-9.
37. ALBLOUSHI S S, MURRAY F E, CALLAGY G, COURTNEY M G, O'KEANE J C, KAY E. Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland. Eur J Gastroenterol Hepatol 1998; 10: 69-73.
38. MULLER R. The natural history of hepatitis C: clinical experiences. J Hepatol 1996; 24(2 Suppl): 52-4.
39. BORTOLOTTI F, RESTI M, GIACCHINO R, AZZARI C, GUSSETTI N. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997; 130: 990-3.
40. LEON P, LOPEZ J A, ELOLA C, QUAN S, ECHEVARRIA J M. Typing of hepatitis C virus antibody with specific peptides in seropositive blood donors and comparison with genotyping of viral RNA. Vox Sang 1997; 72: 71-5.